Xilio Therapeutics, Inc. Share Price

NASDAQ: XLO

Small Cap

$0.75

-0.01

(-1.58%)

as on September 18, 2025 at 1:29 am IST

$₹

Xilio Therapeutics, Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$0.75
Day's Price Range
$0.77
$0.75
2.67%
Upside
52 Week's Low
52 Week's High
$0.62
52-Week Price Range
$1.7
$0.75
18.00%
Downside
126.67%
Upside

Xilio Therapeutics, Inc. share price movements today

Previous Close: $0.77
Open: $0.77
Volume: 461.8K
Day's Low - High: $0.75 - $0.77
52 Week Low - High: $0.62 - $1.7

Xilio Therapeutics, Inc. Historical Returns

1 Month Return: + 6.59 %
3 Month Return: + 14.08 %
1 Year Return: -7.5 %
3 Year Return: -74.88 %
5 Year Return: 0 %

Xilio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Xilio Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.7M

EPS (TTM)

-0.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-55.0M

Revenue (TTM)

15.0M

Profit Margin

0.00%

Return On Equity TTM

2179400.00%

Xilio Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xilio Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Xilio Therapeutics, Inc.	BUY	$39.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Xilio Therapeutics, Inc. Stock including INR - Dollar returns

The Xilio Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Xilio Therapeutics, Inc. investment value today

Current value as on today

₹97,546

Returns

₹2,454

(-2.45%)

Returns from Xilio Therapeutics, Inc. Stock

₹7,407 (-7.41%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Xilio Therapeutics, Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Therapeutics, Inc.. Average target price of $2

Xilio Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Xilio Therapeutics, Inc..

What analysts predicted

62.5%UPSIDE

Target Price

$2

Current Price

$0.75

Analyzed by

7 Analysts

Target

$2.00

Xilio Therapeutics, Inc. target price $2, a slight upside of 62.5% compared to current price of $0.75. According to 7 analysts rating.

Xilio Therapeutics, Inc. Stock's Interest Amongst Investors

Search interest for Xilio Therapeutics, Inc. Stock has increased by 85% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:85% versus previous 30 day period

Xilio Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	2	2	2	1	2	8
Gross Profit	0	0	0	0	2	2	2	1	2	8
Operating Income	-23	-23	-20	-17	-17	-14	-14	-13	-13	-14
EBITDA	-23	-23	-19	-16	-16	-14	-14	-13	-13	-13
Interest Expense	0	1	0	0	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-22	-22	-19	-16	-17	-13	-14	-13	-13	-15
Income Tax Expense	0	-1	-	-1	1	-	-	-	-	-
Net Income	-21	-21	-19	-16	-17	-13	-14	-13	-13	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-592.80%	-590.79%	-619.53%	-759.45%	-452.73%	-195.99%

Xilio Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	6
Gross Profit	0	-1	-1	-1	-1	6
Operating Income	-19	-54	-75	-89	-79	-60
EBITDA	-17	-53	-73	-87	-73	-58
Interest Expense	-	0	0	0	0	0
Depreciation	0	1	1	1	1	1
Income Before Tax	-17	-55	-75	-88	-76	-58
Income Tax Expense	0	0	-1	0	0	-
Net Income	-17	-55	-74	-87	-76	-58
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-918.05%

Xilio Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-19	-16	-17	-17	-13	-14	-13	-13	-15
Operating Cash Flow	-16	-13	-	-10	19	-13	-14	28	-14
Investing Cash Flow	0	0	-	-	0	0	0	0	0
Financing Cash Flow	0	0	-	0	20	0	8	4	47
Change in Cash	-17	-15	-	-10	40	-13	-5	33	32

Xilio Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-55	-75	-88	-76	-58
Operating Cash Flow	-36	-80	-75	-68	-18
Investing Cash Flow	-2	-1	-1	0	0
Financing Cash Flow	10	260	0	-6	29
Change in Cash	-28	178	-77	-75	10

Global Institutional Holdings in Xilio Therapeutics, Inc.

Funds	Holdings
Bain Capital Life Sciences Investors, LLC	8.82%
Merck & Co Inc	2.87%
Takeda Pharmaceutical Co Ltd	2.85%
Morgan Stanley - Brokerage Accounts	2.23%
Vanguard Group Inc	2.19%

See all

Insights on Xilio Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, XLO stock has moved up by 3.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 186.4%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 75.9%

About Xilio Therapeutics, Inc.

xilio is a waltham, massachusetts-based biopharmaceutical company focused on defeating cancer. the company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, xilio, derived from the latin term, ex nihilo, meaning creation or big-bang. xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. to learn more, please visit www.xiliotx.com.

Organisation	Xilio Therapeutics, Inc.
Headquarters	828 Winter Street, Waltham, MA, United States, 02451
Industry	Services
CEO	Dr. Rene Russo BCPS, Pharm.D.
E-voting on shares	Click here to vote

Key Management of Xilio Therapeutics, Inc.

Name	Title
Mr. Christopher Frankenfield	CFO & COO
Dr. Katarina Luptakova M.D.	Chief Medical Officer
Mr. Kevin M. Brennan	Senior Vice President of Finance & Accounting
Dr. Uli Bialucha Ph.D.	Chief Scientific Officer
Mr. Nathan McBride	Chief Information Officer
Ms. Caroline Hensley	Chief Legal Officer
Dr. Scott Coleman Ph.D.	Chief Development Officer
Dr. Rene Russo BCPS, Pharm.D.	President, CEO & Director

FAQs

What is Xilio Therapeutics, Inc. share price today?

Xilio Therapeutics, Inc. share price today is $0.75 as on September 18, 2025 at 1:29 am IST at the close of the market. Xilio Therapeutics, Inc. share today touched a day high of $0.77 and a low of $0.75.

What is the 52 week high and 52 week low for Xilio Therapeutics, Inc. share?

Xilio Therapeutics, Inc. share touched a 52 week high of $1.7 on February 12, 2025 and a 52 week low of $0.62 on August 1, 2025. Xilio Therapeutics, Inc. stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.75,which is 55.88% down from its 52 week high and 21.95% up from its 52 week low.

What is Xilio Therapeutics, Inc.'s market capitalisation today?

Xilio Therapeutics, Inc. market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Xilio Therapeutics, Inc. Stock (XLO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Xilio Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xilio Therapeutics, Inc. Shares that will get you 2.0000 shares as per Xilio Therapeutics, Inc. share price of $0.75 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xilio Therapeutics, Inc. Stock (XLO) from India?

Indian investors can start investing in Xilio Therapeutics, Inc. (XLO) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 4:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Xilio Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:41 pm IST). Based on Xilio Therapeutics, Inc. share’s latest price of $0.75 as on September 18, 2025 at 1:29 am IST, you will get 13.3333 shares of Xilio Therapeutics, Inc.. Learn more about fractional shares .